[CAS NO. 42553-65-1]??Crocin
PRODUCTS SPECIFICATIONS [42553-65-1]
DESCRIPTION [42553-65-1]
Overview
| MDL | MFCD11044877 |
|---|---|
| Molecular Weight | 976.96 |
| Molecular Formula | C44H64O24 |
| SMILES | O[C@@H]([C@H](O)[C@H]1O)[C@H](O[C@H]1OC(/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C(O[C@@H]([C@@H]([C@@H](O)[C@@H]2O)O)O[C@@H]2CO[C@@H]([C@@H]([C@@H](O)[C@@H]3O)O)O[C@@H]3CO)=O)=O)CO[C@@H]([C@@H]([C@@H](O)[C@@H]4O)O)O[C@@H]4CO |
4 Publications Citing Use of MCE
Summary
Crocin (Crocin I) is a nutraceutical and the main constituent isolated from the stigmas of Crocus sativus with immense pharmacological properties as anti-inflammatory, anticancer, antidepressant and anticonvulsant [1] .
Clinical Trial
| NCT Number | Sponsor | Condition | Start Date | Phase |
|---|---|---|---|---|
| NCT05504148 | Qilu Hospital of Shandong University |
Breast Cancer
|
March 29, 2021 | Not Applicable |
| NCT04936490 | Shiraz University of Medical Sciences |
Chorioretinopathy, Central Serous
|
July 1, 2021 | Phase 1 |
| NCT03375814 | Mashhad University of Medical Sciences |
Osteoarthritis, Knee
|
July 20, 2016 | Phase 3 |
| NCT04163757 | National Nutrition and Food Technology Institute|Vahideh Behrouz|Ali Dastkhosh |
Type 2 Diabetes
|
January 20, 2019 | Not Applicable |
Appearance
Solid
Source
Shipping
Room temperature in continental US; may vary elsewhere.
Storage
4°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
Solvent & Solubility
DMSO : 125 mg/mL ( 127.95 mM ; Need ultrasonic)
Stock Solutions
| Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
|---|
| 1 mM | 1.0236 mL | 5.1179 mL | 10.2358 mL |
| 5 mM | 0.2047 mL | 1.0236 mL | 2.0472 mL |
| 10 mM | 0.1024 mL | 0.5118 mL | 1.0236 mL |
-
1.
-
2.
Add each solvent one by one: 10% DMSO >> 90% (20% SBE-β-CD in saline)
Solubility: ≥ 2.08 mg/mL (2.13 mM); Clear solution
Synonyms